SCHEMBL4134704

SCHEMBL4134704

CCCCCCCCCC(=O)NC(=O)Nc1cc(C)nn1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.56
MEN1 O00255 4/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
KDM4E B2RXH2 2/20 0.44
HTT P42858 1/20 0.44
SOAT2 O75908 2/20 0.42
SOAT1 P35610 2/20 0.42
FAAH O00519 1/20 0.41
NPY1R P25929 1/20 0.39
NPY2R P49146 1/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPK14 Q16539 1/20 0.39
ALDH1A1 P00352 2/20 0.39
DEGS1 O15121 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1863437 0.83 KMT2A (0.51) KMT2AMEN1SMN1; SMN2KDM4EHTT
SCHEMBL1861766 0.83 KMT2A (0.51) KMT2AMEN1SMN1; SMN2KDM4EHTT
SCHEMBL4136924 0.81 MEN1 (0.58) KMT2AMEN1SMN1; SMN2KDM4EHTT
SCHEMBL4137645 0.81 MEN1 (0.58) KMT2AMEN1SMN1; SMN2KDM4EHTT
SCHEMBL4132087 0.81 MEN1 (0.58) KMT2AMEN1SMN1; SMN2KDM4EHTT
SCHEMBL4135897 0.81 MEN1 (0.58) KMT2AMEN1SMN1; SMN2KDM4EHTT
SCHEMBL4138545 0.79 KMT2A (0.48) KMT2AMEN1SOAT2SOAT1ALDH1A1
SCHEMBL4142888 0.78 MEN1 (0.61) KMT2AMEN1SMN1; SMN2KDM4EHTT
SCHEMBL9164082 0.77 SMN1; SMN2 (0.58) KMT2AMEN1SMN1; SMN2KDM4EHTT
SCHEMBL4145122 0.77 KMT2A (0.48) KMT2AMEN1SMN1; SMN2KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192192-A1 INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA TOUCH BIONICS LIMITED (GB) 2009-07-30 US disclosed
US-20090192192-A1 INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA TOUCH BIONICS LIMITED (GB) 2009-07-30 US disclosed
US-20090192192-A1 INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA TOUCH BIONICS LIMITED (GB) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192192-A1 INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA PGLS, TFPI, Q6ZSR9 KMT2A 3636/4885MEN1 4659/4885SMN1; SMN2 4885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.